Active Stock Alerts: Apple, Teva, NVIDIA, UQM, Cree May 25th
Apple Inc. (NASDAQ:AAPL): Piper Jaffray this morning in a note to investors highlighted the reasons for why it looks for Apple shares to reach $1,000 in the next couple of years. The firm expects Apple will continue to benefit from consumers’ increasing desire for mobile devices and believes the company’s 2012 product roadmap will demonstrate its ability to innovate. Piper reiterates an Overweight rating on Apple shares with a 12-month price target of $910.
Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): Piper Jaffray recommends avoiding Teva shares despite the pullback in recent weeks ahead of management’s tempered guidance expectations yesterday. The firm sees limited visibility for the company’s generics businesses and lowered its price target for shares to $44 from $45.
NVIDIA Corporation (NASDAQ:NVDA): FBR Capital says the risk/reward for shares of NVIDIA is attractive following the recent sell-off and maintains an Outperform rating on the name following the company’s analyst day.
UQM TECHNOLOGIES INC (AMEX:UQM): Needham lowered its target on UQM shares to $3 since the firm is uncertain about the timing of orders from multiple customers. However, Needham said it is bullish on the company’s long-term prospects and maintains a Buy rating on the stock.
Cree Inc. (NASDAQ:CREE): Maxim believes the decline in Cree shares following the CFO departure is unwarranted and sees a buying opportunity at current levels. The firm sees no smoking gun implications in John Kurtzweil’s resignation as he has a history of leaving positions for smaller companies. Maxim keeps a Buy rating on Cree with a $38 price target.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.